Negotiable: Paramount Recruitment: Bioinformatics Pipeline Developer Cambridge This is a great opportunity for a strong Bioinformatics Pipeline Developer to join the R&D Computatio Cambridge, England

Competitive Salary: EMBL: About this position We are seeking to recruit an experienced and enthusiastic Purchasing Assistant to work in our small Purchasing team at the Euro Hinxton, Cambridgeshire, England

Competitive Salary: EMBL: About this position Training is a core activity across EMBL-EBI, involving almost every part of the organisation and coordinated by a team of 28 pe Hinxton, Cambridgeshire, England

Funding Opportunity PAS-21-150 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) seeks innovative grant applications in nonmalignant hematology research that will steer the field in new directions. Applications to this FOA should propose proof of principle research that is tightly focused into one specific aim, which can be accomplished within a 1-3 year project period, and is directed at validating novel concepts and approaches that promise to open new pathways for discovery.

£37,865- £45,359: Wellcome Sanger Institute: The Opportunity:   We are looking for a Senior Bioinformatician to join our Cellular Genetics Informatics (CGI) team to provide bioinformatics expe... Hinxton, Cambridgeshire

Competitive Salary: EMBL: About this position ELIXIR is seeking a Technical Coordinator to join the dynamic and international Human Genomics and Translational team at the EL Hinxton, Cambridgeshire, England

Competitive Salary: EMBL: About this position We are looking to recruit an experienced Full Stack developer to join the Literature Services Team at the European Bioinformati Hinxton, Cambridgeshire, England

Funding Opportunity RFA-MH-21-170 from the NIH Guide for Grants and Contracts. This Limited Competition Funding Opportunity Announcement (FOA) invites applications to continue the activities of the National NeuroAIDS Tissue Repository (NNTC), a data coordination center for the CHARTER cohort (a cohort of individuals living with HIV on Antiretroviral therapy). CHARTER research sites and DCC will continue to collect and provide research data as well as research specimens to interested investigators to address high priority research areas in NeuroHIV.

Notice NOT-TR-21-023 from the NIH Guide for Grants and Contracts

D. E. Shaw Research is seeking Ph.D.–level scientists to join our New York–based team.  This is a unique opportunity to develop and work with transformative

Notice NOT-NS-21-025 from the NIH Guide for Grants and Contracts

Notice NOT-GM-21-020 from the NIH Guide for Grants and Contracts

Notice NOT-OD-21-071 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-21-191 from the NIH Guide for Grants and Contracts. Nearly 40,000 people in the U.S. die from firearm-related deaths each year, primarily from suicide (60%) or homicide (37%), and many more have experienced non-fatal firearm injuries, both intentional and nonintentional. The Joint Explanatory Statement accompanying the Consolidated Appropriations Act, 2021 (Public Law 116-260) included funding for the NIH to conduct research on firearm injury and mortality prevention and recommended that NIH take a comprehensive approach to studying the underlying causes and evidence-based methods of prevention of firearm injury, including crime prevention. Within the legislative mandates and limitations of NIH funding (NOT-OD-21-058, NOT-OD-21-056), the NIH encourages research to improve understanding of the determinants of firearm injury, the identification of those at risk of firearm injury (including both victims and perpetrators), the development and piloting of innovative interventions to prevent firearm injury and mortality, and the examination of approaches to improve the implementation of existing, evidence-based interventions to prevent firearm injury and mortality.

Funding Opportunity PAR-21-192 from the NIH Guide for Grants and Contracts. Nearly 40,000 people in the U.S. die from firearm-related deaths each year, primarily from suicide (60%) or homicide (37%), and many more have experienced non-fatal firearm injuries, both intentional and nonintentional. The Joint Explanatory Statement accompanying the Consolidated Appropriations Act, 2021 (Public Law 116-260) included funding for the NIH to conduct research on firearm injury and mortality prevention and recommended that NIH take a comprehensive approach to studying the underlying causes and evidence-based methods of prevention of firearm injury, including crime prevention. Within the legislative mandates and limitations of NIH funding (NOT-OD-21-058, NOT-OD-21-056), the NIH encourages research to improve understanding of the determinants of firearm injury, the identification of those at risk of firearm injury (including both victims and perpetrators), the development and evaluation of innovative interventions to prevent firearm injury and mortality, and the examination of approaches to improve the implementation of existing, evidence-based interventions to prevent firearm injury and mortality.

Funding Opportunity RFA-AI-21-005 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits applications for a Tropical Medicine Research Centers Coordinating Center (TMRC CC) for the Tropical Medicine Research Centers (TMRC). The TMRC CC will oversee and coordinate efforts across the TMRCs related to data management, data and specimen sharing, scientific collaboration, creation and maintenance of a virtual sample repository, organizing annual meetings, managing an Opportunity Fund to support research by junior and early-stage investigators, and liaising with United States Government (USG) counterparts and other stakeholders.

Funding Opportunity RFA-AI-21-004 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) solicits research applications focused on the etiology, epidemiology, pathogenesis, clinical manifestations, diagnosis, prevention, treatment and control of select Neglected Tropical Diseases (NTDs) in endemic areas. The Tropical Medicine Research Centers (TMRCs) are intended to advance NIAIDs global research effort by targeting research endeavors to: develop novel diagnostic, prevention and therapeutic strategies adapted for the unique needs of low and middle-income countries (LMICs), as classified by the World Bank; create and sustain in-country research capacity; stimulate scientific collaboration and global partnerships; work with in-country scientists to develop training; provide opportunities for junior and early-stage investigators to conduct research on NTDs; and facilitate sample sharing to support translational research to develop or evaluate new drugs, diagnostics, vaccines, therapeutics, or vector control strategies.

Funding Opportunity PAR-21-193 from the NIH Guide for Grants and Contracts. The purpose of the NIOSH Support for Conferences and Scientific Meetings (U13) is to support high quality scientific meetings, conferences, and workshops that are relevant to NIOSHs scientific mission and that promote occupational safety and health, NIOSH program priorities, and public health. The conference program is integral to the overall mission of NIOSH. An application should address and advance important areas of research in the field of occupational safety and health of particular interest to NIOSH programs and the National Occupational Research Agenda.

Funding Opportunity PAR-21-161 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to establish a joint initiative between the National Eye Institute (NEI) and the Vision Research Program (Vision Research Program) of the Department of Defense (DOD). Through this FOA, the NEI will support meritorious VRP proposals that were unable to be funded by the DOD.

Funding Opportunity PAR-21-141 from the NIH Guide for Grants and Contracts. It is essential to expand and diversify the skilled AD/ADRD clinical trial workforce. The intent of this Funding Opportunity Announcement (FOA) is to encourage applications that develop creative and innovative short courses to train the next generation of AD/ADRD clinical trialists in state-of-the-art clinical research skills.